Free EHR, EHR and Healthcare IT Newsletter Want to receive the latest updates on EHR, EMR and Healthcare IT news sent straight to your email? Get all the latest EHR News for FREE!

CynergisTek Expands Leadership Team to Support Company Growth

Adam Hawkins Advances as Vice President of Sales and Marketing to Drive Continued Expansion Amid Increased Demand for Privacy and Security Expertise in Healthcare

Austin, Texas, June 29, 2015CynergisTek™, an authority in health information privacy, security and compliance, today announced it has expanded its leadership team with the addition of Adam Hawkins as Vice President of Sales and Marketing. Effective July 1, 2015, Adam will be responsible for the sales and marketing operations at CynergisTek, as well as the strategic planning, development and implementation of the company’s Managed Services and Vendor Security Management offerings. In addition, Adam will continue to ensure a high-level of support is maintained across the company’s client base of healthcare provider organizations. Adam originally joined CynergisTek as Director of Client Services in 2012, and was an integral part of developing a highly successful sales team as the company restructured its sales and marketing efforts from the ground up.

Adam’s transition to this executive role will be critical in effectively managing unprecedented company growth spurred by increased demand for privacy and security expertise in healthcare. The company has experienced a 70 percent increase in revenue over the last calendar year, and has rapidly expanded its workforce, requiring seasoned leadership in sales, marketing and client services. Adam has more than a decade of experience in healthcare information security and clinical technologies, positioning him well to manage the company’s sales force, marketing department and partner alliances.

“Adam’s commitment to matching providers with the best possible solutions for their privacy and security needs has been instrumental in fostering the trust our clients have come to know and rely on us for,” said Dr. Michael Mathews, CynergisTek Co-Founder and COO. “Adam has a proven track record of ensuring client success, and we are pleased to have him join the executive team where he can exercise his leadership skills and provide strategic direction as we continue to grow.”

Complex regulations, looming enforcement action and prevalent data breaches in the healthcare industry have made data security a top priority for most providers. This increased focus on information security has led many organizations to seek outsourced expertise, driving business for CynergisTek and opening the door to new career opportunities at the company for those with education and experience in information technology.

“It’s been the opportunity of a lifetime to be a part of a company that is leading the healthcare industry at such a critical time,” said Adam. “It has been very rewarding to help CynergisTek clients navigate today’s dynamic threat environment, and I am looking forward to stepping into my new role where I can fully dedicate myself to adding value across the board.”

Prior to joining CynergisTek, Adam was a Regional Sales Executive at Diebold and DrFrist and Director of Sales & Technology at VisionTree. Adam holds a Bachelor’s of Science in Information and Decision Systems and Political Science from California State University, San Diego.

About CynergisTek

CynergisTek is a top-ranked information privacy and security consulting firm. The company offers solutions to help organizations measure privacy and security programs against regulatory requirements and assists in developing risk management best practices. Since 2003 the company has served as a partner to hundreds in the healthcare industry. CynergisTek is also dedicated to supporting and educating the industry by contributing to relevant associations such as HIMSS, AHIMA, HFMA, HCCA, AHIA, AHLA, IAPP and CHIME. CynergisTek was recognized by KLAS®, as one of three firms provider organizations turn to most for privacy and security assistance in its groundbreaking report released in May 2014, entitled “Security and Privacy Perception 2014: High Stakes, Big Challenges.” For more information visitwww.cynergistek.com, call 512.402.8550 or email info@cynergistek.com.

June 29, 2015 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Survey Shows Insider Threats on the Rise: Organizations Experience an Average of 3.8 Attacks per Year

Survey by Crowd Research Partners Shows Endpoints Are by Far the Most Common Launch Point for an Insider Attack; Highlights Need for Robust Endpoint Security and Policies

VERO BEACH, FL − (June 24, 2015)SpectorSoft™, a leader in the user activity monitoring and behavior analysis market, today released results of the Insider Threat Report, a crowd-based research project that was done in cooperation with the 260,000+ member Information Security Community on LinkedIn and Crowd Research Partners to gain more insight into the state of insider threats and solutions to prevent them. The final report results were based on a comprehensive survey of over 500 cybersecurity professionals from organizations of varying sizes across many industries; the results highlight the increasing need for better security practices and solutions to reduce the risks posed by insider threats.

Among the report’s findings:

The Rise of Insider Attacks: A majority of security professionals (62 percent) saw a rise in insider attacks over the last 12 months, while 22 percent saw no rise, and 16 percent were unsure if they had been attacked or not.

Frequency of Insider Attacks: Forty-five percent of respondents cannot determine whether their organizations experienced insider attacks in the last 12 months. Twenty-two percent said they experienced between one and five attacks, and 24 percent of organizations believe they experienced no attacks at all. Of the respondents who were willing to admit they suffered an insider attack, the average number was 3.8 incidents per organization per year.

Cost of Remediation: The overall average cost of remediating a successful insider attack is around $445,000. With an average risk of 3.8 insider attacks per year, the total remediation cost of insider attacks can quickly run into the millions of dollars.

Monitor Insider Activity on the Endpoint: The survey highlights the need for robust endpoint security and policies; respondents identified endpoints as the most common launch point for insider attacks (56 percent); this was followed by networks (43 percent) and mobile devices (42 percent).

Top Insider Threats: Organizations overwhelmingly maintained that data loss was the top concern regarding insider threats. When asked which types of insider attacks were most concerning, 63 percent of respondents said data leaks, 57 percent said inadvertent data breaches and 53 percent said malicious data breaches.

Vulnerable Data: Sixty-four percent of respondents feel extremely, very or moderately vulnerable to insider threats. Due to its value to attackers, the most vulnerable type of data is customer data (57 percent). This was closely followed by intellectual property (54 percent) and financial data (52 percent).

Internal versus External Attacks: Sixty-two percent of respondents find it more difficult to detect internal threats than external threats, while 38 percent cannot determine which type of threat is most difficult to detect.

Monitoring the Threat: When it comes to threat monitoring, 75 percent of companies monitor the security controls of their applications, 60 percent monitor a majority of all of their key IT assets, while only 21 percent continuously monitor user behavior taking place on their networks.

“The survey and report called out a rise in insider threats, the difficulty in detecting them, and the significant costs in cleaning up after a successful insider attack,” said Mike Tierney, COO, SpectorSoft.  “Companies need the ability to detect for anomalies in user behavior to make sure they are aware of the threats that exist within their organizations, because insiders will deviate from their normal behavior patterns when planning and executing an attack.”

About SpectorSoft

SpectorSoft is the leader in user activity monitoring and an innovator in user behavior analysis software. SpectorSoft has helped more than 36,000 businesses, government organizations, schools and law enforcement agencies improve how they address security and achieve compliance. SpectorSoft award-winning solutions include enterprise-grade insider threat detection software, a powerful user activity monitoring solution deployed by thousands of companies in more than 110 countries, robust Event and Security Log Management, and the world’s leading employee investigation tool. For more information, please visitwww.spectorsoft.com.

June 26, 2015 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Zoeticx Leverages Crowd Funding to Introduce TruRecord, Medical Prescribing Software That Will Address 2.2 Million Adverse Drug Reactions in U.S.

First EHR-integrated, Precise and Personalized, Mobile Platform to Leverage Advances in DNA Testing for Better Patient Outcomes and Lower Malpractice Payouts

June 29, 2015; San Jose, Calif — Zoeticx, Inc., the developer of medical software that bridges the gap between medical data and quality patient care, today announced a crowd funding campaign for TruRecord, the first subscriber-based, medical prescribing software to leverage advanced DNA testing technology for optimal drug analysis and prevention of adverse drug reactions.

The company is raising funds for a fall launch of TruRecord on medical crowd funding site Medstartr http://www.medstartr.com/projects/662-trurecord

TruRecord improves patient outcomes by reducing the 80,000 annual deaths due to drug adverse reactions, resulting in 289 billion spent annually on malpractice payouts. CDC ranks this as the fourth highest cause of deaths in US. With 30 new medications introduced yearly and 25 percent of patients on multiple medications, the need is growing.  The CDC also ranks this as the fourth highest cause of death in the U.S. after heart disease, cancer and strokes.

TruRecord is designed to foster better patient outcomes by helping to prevent the 100,000 deaths yearly from drugs that are prescribed properly and 80,000 deaths from those which are not, resulting in 289 billion spent annually on malpractice payouts.

Breaking Through Drug Analysis Limitations

Through an intuitive visualization of drug-to-drug interactions, drug-to-allergy interactions, and drug to DNA metabolization, medical professionals can now create what-if scenarios for drug issues, enabling providers to personalize prescriptions. This capability breaks through providers’ drug analysis limitations and the burdensome task of scanning and searching text and tables to identify adverse reaction data which is often complex.

These scenarios can now also be more complete with accurate patient medical information from any facility, including integration from existing hospital EHR’s through Zoeticx’s Patient-Clarity Platform which connects disparate EHR records and enables medical system interoperability.

Mobile Devices, HIPAA Compliance

TruRecord client interfaces are supported on mobile and web interfaces, providing precise, personalized medication prescriptions. TruRecord accesses patient medical records via an on-demand, real time access from EHR / EMR systems. Without data duplication, TruRecord complies with all required secure patient privacy protection outlined by HIPAA.

“We built Zoeticx to help medical systems address interoperability, lower accidental deaths and bridge the gap between medical data and better patient outcomes,” said Thanh Tran, CEO, Zoeticx. “Today our goal is the same, but a shift toward an additional focus—adverse drug reactions. We are ushering in an era where we can leverage the fruits of DNA research to bring more precise and accurate prescriptions to those who rely on them. TruRecord takes the guess work out of drug interactions and patients by delivering security, peace of mind and accuracy.”

About Zoeticx

Zoeticx offers software solutions for the healthcare industry which are dedicated to improving patient outcomes, enhancing the quality of care, containing costs, and simplifying administration. These solutions offer an immediate increase in the quality of care by delivering the right information to the right caregiver at the right time, in a manner that can be easily understood.  Additionally, as the Affordable Care Act continues to roll out, healthcare providers will face new challenges which arise whenever there is a transition from an old system of doing business to a new one. Zoeticx helps solve those challenges, allowing care providers to focus on what is most important, the patient. www.Zoeticx.com For additional information contact Glass Lantern PR at @glasslanternpr.com.

June 25, 2015 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Nebraska Medicine and Epic ahead of their time with a new patient engagement app for the Apple Watch

Information about appointments, medications and more coming to the wrists of patients with Apple’s newest device

Omaha, Neb – Apple has always been about innovation. The same can be said for Epic, the Verona, Wisconsin-based healthcare software company whose customers manage medical records for more than half the U.S. population, including patients at Nebraska Medicine. Now, Epic and Nebraska Medicine announce one of the first efforts to improve the patient experience using Apple’s first wearable device.

“We’re always looking for ways to improve the satisfaction of our patients,” said Michael Ash, M.D., chief transformation officer at Nebraska Medicine. “We recognize that as more of our patients use devices like the Apple Watch, we not only have to be able to use that technology to initially provide convenience for them, but we also have to envision how we can also improve patient outcomes via use of the device in the future.”

Epic’s MyChart app for Apple Watch, available now on the App Store, lets patients view messages from their care providers, upcoming appointment details, and information on their active medications. They can also see notices when new test results, billing statements and health maintenance reminders are accessible on their iPhones.

“It’s great to see Nebraska Medicine help lead the way on patient engagement with the Apple Watch,” says Sumit Rana, Epic’s senior vice president for research and development. “Wearables such as the Apple Watch have great potential to empower patients as active participants in their own healthcare and wellness while improving the overall care experience.”

Epic has development in the works based on the Apple Watch’s ability to “tap” wearers on the wrist to get their attention. Diabetic patients will be able to get reminders to test their blood sugar regularly, for example. Care organizations will also be able to use the watch to help patients get quicker access to high-demand specialty visits and services. Epic’s Fast Pass On the Go feature would allow a patient with an appointment three weeks out to get an Apple Watch alert if an earlier slot opens up – when another patient cancels an appointment, for example – and accept the new appointment time from the watch.

An Apple Watch app is also available for physicians who use Epic’s Haiku mobile application for the iPhone. Doctors can view their schedule, hospitalized patients and clinical summaries. They can also use Siri’s speech-to-text functionality to record a clinical note or a MyChart message to send to a patient.

Nebraska Medicine is the most esteemed academic health system in the region offering exceptional patient care combined with innovative research and education. Committed to advancing quality health care, Nebraska Medicine represents the clinical integration of The Nebraska Medical Center, the state’s largest and highest rated hospital, Bellevue Medical Center and UNMC Physicians. Our newly integrated organization allows us to strengthen our services by expanding collaboration with our partners and providing patients access to more than 1,000 physicians and 678 licensed hospital beds as well as approximately 40 specialty and primary care clinics in Omaha and the surrounding area. Find Nebraska Medicine online at www.nebraskamed.com.

June 19, 2015 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Vocera Clinical Workflow Engine Improves Clinical Integrations and Reduces Costs

SAN JOSE, Calif., June 16, 2015 (GLOBE NEWSWIRE) — Mobile healthcare communications company, Vocera (NYSE:VCRA), today introduced the Vocera Clinical Workflow Engine to streamline integrations between the Vocera Communication System and clinical systems such as nurse call and electronic health records (EHRs). By integrating Vocera with these and other solutions, hospitals can automatically send an alert to the nurse assigned to a particular patient based on the intelligent workflow defined in the system, improving patient safety and reducing the noise and annoyance of broadcast alarms.

Vocera’s Clinical Workflow Engine eliminates the need for third-party middleware. It streamlines clinical workflows for voice, messaging, patient monitoring alerts and alarms, nurse calls, EHRs, bed management and other clinical systems. As part of the Vocera Communications System, this solution also reduces costs and the number of vendors required to support clinical workflows, simplifying care team collaboration.

A recent Vocera study sent to nearly 500 high-level hospital employees, conducted by TechValidate, showed 84 percent of respondents find value in Vocera integrations with patient monitoring; 75 percent find value in Vocera’s ability to integrate with EHRs; and 87 percent indicated that Vocera integrations with nurse call systems were important.1 This workflow solution gives Vocera users the ability to deliver the right information, to the right person, on the right device, at the right time.

Using the Vocera Clinical Workflow Engine as the single source of information exchange improves accuracy and consistency within the communication data flow, and enables advanced workflow capabilities in reporting and analytics. For example, by integrating alert and alarm systems with the Vocera Clinical Workflow Engine, care teams can better understand alarm trends and identify potential workflow gaps with detailed analytics filtered by bed, unit, staff, alarm type, alarm density, distribution and response time. Between 72 and 99 percent of all clinical alarms do not require clinical intervention so this contextual data plays a crucial role in improving patient safety and care team efficiency while reducing the growing concerns of alarm fatigue.

“Real-time communication requires seamless integration between systems to ensure clinicians have the right information at the right time to optimize workflow, improve patient care and safety, and reduce costs,” said Gautam M. Shah, vice president of product management at Vocera. “The Vocera Clinical Workflow Engine allows the Vocera Communication System to operate as a single-source for clinical integrations, simplifying and improving the accuracy and efficiency of communication, data flow, reporting and analytics.”

For more about Vocera Clinical Workflow Engine, please visit http://www.vocera.com/resource/vocera-clinical-workflow-engine-solution-brief.

About Vocera

Vocera Communications, Inc. (NYSE:VCRA) is a mobile healthcare communications company that provides enterprise-class solutions. Widely recognized for developing smarter ways to communicate, Vocera helps care teams collaborate more efficiently by delivering the right information, to the right person, on the right device, at the right time, anywhere. Vocera solutions are installed in more than 1,200 organizations worldwide, improving quality, efficiency, safety and outcomes. Via the company’s research collaborative, the Experience Innovation Network, Vocera also drives thought leadership for the healthcare industry and new standards in care delivery to elevate patient, family, nurse and physician experiences. Vocera is headquartered in San Jose, California, with offices in San Francisco, Tennessee, Canada, India, United Arab Emirates, and the United Kingdom. For more information, visit www.vocera.com and @VoceraComm on Twitter.

1 Source: TechValidate. http://www.techvalidate.com/product-research/vocera-communication-system

June 16, 2015 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Dell and Translational Genomics Research Institute Help Support the Fight Against Pediatric Cancer Across Europe and the Middle East

DELL INNOVATION DAY, COPENHAGEN, Denmark, June 11, 2015 — Dell today announced its extended partnership with Translational Genomics Research Institute (TGen) to help clinical researchers and doctors globally expand the reach and impact of the world’s first Food and Drug Administration (John,FDA)-approved personalized medicine trial for pediatric cancer. The renewed commitment includes an additional $3 million Dell grant to support continued collaboration with TGen and support theNeuroblastoma and Medulloblastoma Translational Research Consortium’s (NMTRC) expanded  pediatric cancer clinical trials in EMEA, starting with sites in France and Lebanon. This is the second grant Dell has provided TGen to accelerate treatment of pediatric cancer, bringing its total contributions to more than $15 million since 2011.

The grant will also allow TGen to use Dell technology to bring genomic sequencing to point of diagnosis and enable TGen to extend its capabilities past pediatric cancer to support sequencing for other medical conditions affecting children including rare childhood diseases. By leveraging the capacity of Dell’s technology infrastructure, TGen is able to redirect some of its attention and resources to research rare disease sequences and help families get answers more quickly.

With most large hospitals lacking the time and budget to research pediatric cancer treatments, TGen’s aim is to reach and treat as many children as possible. However, when looking to support patients globally, it realized that it could no longer manage all of its data processing from the US. With time running out for many of its patients, TGen needed a solution that it could trust and that would reduce the amount of time needed to find and sequence genomic data. Based on a successful partnership in the US, TGen and Dell decided to extend its partnership and expand its support to EMEA.

“Time is of the essence in our line of work so we’re constantly undergoing vendor evaluations to try to find the right tool for the job. Dell understands what we’re trying to accomplish – not an easy claim in the world of quick-fire genome sequencing – and it has the partnerships and hardware to help us do it,” said James Lowey, Vice President of Technology, TGen.

TGen’s extended partnership with Dell will help it optimize a high-performance computing infrastructure to enable researchers to analyze and store massive amounts of genetic data more quickly and reach more patients than ever before. To date, TGen has been able to increase the number of computational hours by 376 percent and reduce the time it takes to analyze a patient’s molecular data – a process that used to take ten days – to six hours. These results will now be replicated in EMEA, as the infrastructure scales easily to handle the increased number of patients across the new sites.

“We are proud to help TGen in EMEA gain the speed and efficiency it needs to ensure that more children can benefit from timely, local and effective treatment.  Pediatric cancer is an issue that affects too many lives and we are committed to delivering benchmark solutions and support to ensure that the team at TGen are able to focus on this most important of work,” said Aongus Hegarty, President, Dell EMEA.

About Dell

Dell Inc. listens to customers and delivers innovative technology and services that give them the power to do more. As one of the leading providers of end-to-end IT solutions for healthcare worldwide, Dell helps healthcare organizations to simplify administration; coordinate and manage patient care; transition from episodic care to prevention and wellness management; and ultimately to deliver personalized medicine. As part of the company’s commitment to put technology and expertise to work where it can do the most good for people and the planet, Dell has been working with TGen since 2011 to accelerate pediatric cancer treatment. Learn more at http://www.dell.com/childrenscancercare or follow @DellHealth on Twitter.

About TGen

Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based non-profit organization dedicated to conducting groundbreaking research with life changing results. TGen is focused on helping patients with cancer, neurological disorders and diabetes, through cutting edge translational research (the process of rapidly moving research towards patient benefit).  TGen physicians and scientists work to unravel the genetic components of both common and rare complex diseases in adults and children. Working with collaborators in the scientific and medical communities literally worldwide, TGen makes a substantial contribution to help our patients through efficiency and effectiveness of the translational process. For more information, visit: www.tgen.org.

June 11, 2015 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Patient ID Highlighted as Barrier to Interoperability during Senate HELP Hearing

ANN ARBOR, MI, June 10, 2015 – In a hearing convened by the Senate Committee on Health, Education, Labor and Pensions (HELP) today, witnesses outlined opportunities to improve health information exchange, citing the absence of a nationally-recognized identifier as an ongoing challenge to matching patients to their healthcare data.

Senator Elizabeth Warren (D-MA) cited a 2012 CHIME study of 128 healthcare CIOs and other senior healthcare leaders in which nearly one-fifth indicated that their hospital had experienced an adverse event during the course of the year due to a patient information mismatch.  The Senator spoke to the dangers of patient mismatches and called on witnesses to articulate what Congress and the Office of the National Coordinator for Health IT (ONC) can do to solve this patient safety issue.

CHIME member Craig D. Richardville, MBA, FACHE, Senior Vice President and Chief Information Officer at Carolinas HealthCare System, was among the witnesses that pointed to the need for a consistent method by which to identify patients.  Richardville described the palm scans done within his system, resulting in a 99 percent match rate, but emphasized that the near-perfect match rate is only within his systems.

“This is one of the most public and noteworthy conversations that has taken place on the issue of patient identification,” said CHIME Interim Vice President of Public Policy Leslie Krigstein. “It’s time that Congress recognize the inability to accurately identify patients is fundamentally a patient safety issue.”

The College of Healthcare Information Management Executives (CHIME) has long been an advocate for the accurate, efficient matching of patients with their healthcare data to radically reduce medical errors and save lives. In an effort to find a universal solution for accurately matching patients with their healthcare information, CHIME announced in March that will launch a $1 million challenge later this summer on the HeroX platform.

The hearing, entitled “Health Information Exchange: A Path Towards Improving the Quality and Value of Health Care for Patients,” featured a panel of industry stakeholders gathered to evaluate solutions for improving interoperability.  The hearing is one of several being held by the committee to evaluate electronic health records (EHRs) and the promise of health IT.

In addition to Richardville, witnesses included Christine Bechtel, Advisor to the National Partnership for Women & Families and Chair of the Health IT Policy Committee Consumer Workgroup; Neal Patterson, CEO of Cerner; and Thomas H. Payne, M.D., Chair-Elect of the American Medical Informatics Association (AMIA) and Medical Director of IT Services at UW Medicine, University of Washington School of Medicine.

Despite the nation’s progress with HIT implementation and adoption, Richardville testified that the current health IT ecosystem continues to be a challenge for providers due to lack of interoperability between EHR systems.

“Cost-effective, efficient, and easy to use and integrate health information is foundational to advancing and providing excellent care in this country,” he said.  “Patients and care providers are missing opportunities to improve people’s health and welfare when information is not easily available.”

Richardville outlined several factors for creating a pathway to achieving interoperability including a functional set of standards, data transparency and government-led collaboration among providers, patients, vendors and payers.

“We need clear rules of the road for providers and vendors alike through establishment of functional data and transport standards, methods to measure and test functionalities, with enhanced enforcement tools for regulatory bodies to drive compliance in the marketplace,” Richardville told the committee.

CHIME commends the committee for their ongoing efforts to identify resolute policy actions that can facilitate better patient care through the use of health IT systems.

About CHIME:

The College of Healthcare Information Management Executives (CHIME) is an executive organization dedicated to serving chief information officers and other senior healthcare IT leaders. With more than 1,500 CIO members and over 140 healthcare IT vendors and professional services firms, CHIME provides a highly interactive, trusted environment enabling senior professional and industry leaders to collaborate; exchange best practices; address professional development needs; and advocate the effective use of information management to improve the health and healthcare in the communities they serve.

June 10, 2015 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

eHealth Technologies and Orion Health Announce Partnership

Partnership Enables North Dakota Health Information Network Access to Medical Images, Providing a Comprehensive View of the Patient Record

Rochester, N.Y., June 9, 2015eHealth Technologies, the leading provider of image exchange solutions and Orion Health, a global population health management and healthcare integration company, announced today that they have partnered to enable North Dakota Health Information Network (NDHIN) to provide healthcare providers across the entire state of North Dakota with access to medical images as a part of the state-wide Health Information Exchange (HIE).

eHealth Technologies and Orion Health have signed a strategic partnership agreement that incorporates eHealth Connect® Image Exchange into the Orion Health Open Platform, enabling its users to access, view, compare and transfer fully diagnostic quality medical images such as x-ray, Computed Tomography, Magnetic Resonance Imaging and Ultrasound studies from anywhere they can access the Orion Health platform. Both companies are committed to delivering the critical and relevant health information needed by providers to care for patients when, where and how they need it.

“The partnership between eHealth Technologies and Orion Health will ensure that providers using NDHIN can access and share diagnostic quality medical images through our Open Platform. This partnership will help us positively affect patients’ health by minimizing radiation exposure from unnecessary duplicate imaging exams, while also reducing the cost of care,” said BG Jones, Vice President, Global Partner Alliances, Orion Health.

Gary Larson, Executive Vice President & General Manager, HIE Solutions for eHealth Technologies noted “Our partnership with Orion Health will allow healthcare providers to access their patients’ images from any external connected facility in full diagnostic quality, on a unified image viewing platform with no software to install, in the context of the complete patient record. Physicians will be able to securely collaborate to make care coordination across multiple facilities more efficient and effective.”

Mr. Sheldon Wolf, Health Information Technology Director, NDHIN also expressed excitement about the physician collaboration that is now possible with an image enabled HIE: “Image-enabling NDHIN will equip our providers with the tools they need to conduct real-time image consultations with other caregivers for a faster and more complete diagnosis and treatment. Being able to quickly connect providers with the information they need in sparsely populated areas will greatly enhance patient care.”

About Orion Health Inc.

Orion Health, a population health management company, makes healthcare information available anywhere by providing healthcare IT connectivity in nearly every U.S. state and in over 30 countries worldwide—facilitating care for tens of millions of patients every day. With an inherent ability to interconnect a wide variety of healthcare information systems, Orion Health facilitates data exchange within and among provider organizations, accountable care organizations, health plans, governments and health information exchanges, to improve care coordination, enable population health management, enhance quality of care and help reduce costs. For more information, visit www.orionhealth.com. Connect with us on Twitter, Facebookand LinkedIn.

About eHealth Technologies

eHealth Technologies is the industry-leading provider of continuity of care solutions, serving over half of the nation’s top 100 hospitals, including 12 of the top 17 U.S. News & World Report Honor Roll Hospitals for 2014-2015, and leading health information exchanges (HIEs) across the United States. The company’s eHealth Connect® Referral Pathways solution enhances patient and physician satisfaction by streamlining transitions of care, and assuring physicians have the right healthcare information to care for their patients, right when they need it. As a critical adjunct to HIEs, eHealth Connect® Image Exchange enables the automated access to all types of medical images in the context of the aggregated patient record, in full diagnostic quality, and supports the ability for providers to meet Meaningful Use Stage 2 requirements.  For more information, visit www.eHealthTechnologies.com. Connect with us onTwitter, Facebook and LinkedIn.

About North Dakota Health Information Exchange Network

The mission of the NDHIN is to advance the adoption and use of technology to exchange health information and improve healthcare quality, patient safety and overall efficiency of healthcare and public health services of North Dakota.  The North Dakota Health Information Network creates a safe, secure connection for life’s critical moments. For more information, visit http://www.ndhin.org/.

June 9, 2015 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Logicalis US IDs Eight Little Known Printing Facts Costing Hospitals Millions of Dollars

Solution Provider Unveils Managed Print Services for Healthcare

NEW YORK, June 9, 2015 – When you think about the technologies that hospitals spend millions of dollars on annually, printers probably don’t top the list – but they should.  Experts say hospitals are seeing as much as an 11 percent increase in their annual print volumes driven by Meaningful Use, the Affordable Care Act, ICD-10, and the adoption of electronic record-keeping (EMR/EHR) methodologies.  At the same time, healthcare IT experts have begun to realize they have little visibility into their organizations’ print assets or operations, something which often leads to stockpiling of supplies and, all too often, to a mismatch of equipment and needs.  Recognizing this, Logicalis US, an international IT solutions and managed services provider (www.us.logicalis.com), today announced availability of its Managed Print Services (MPS) for Healthcare, a cloud-based offering specifically designed to generate cost savings by monitoring print activity and providing analytics and automated alerts to optimize supply orders and service requests.

“Sometimes we let the cool new technologies in our industry get in the way of caring for simple, yet really important things that can reduce costs and improve quality,” says Ed Simcox, Practice Leader, Logicalis Healthcare Solutions. “We all use and walk past printers every day in a hospital setting, but how often do we stop and ask if we’re using these assets to the best of our ability? Are things being printed unnecessarily leading us to overpay for and underutilize these assets? How much money do we spend managing these printers, and how many calls does the help desk get? While it may sound mundane, these are important questions to ask.  Everyone is doing more with less money, and hospitals are looking for places to save costs without affecting patient care; with a service-focused partner providing proper oversight, you can literally save millions of dollars enterprise-wide by instituting best practices in a managed print solution.”

Case in Point
One of the world’s leading cancer research institutes was considering updating an aging fleet of more than 2,500 printers with a significant number of locally attached USB devices.  After trying for 60 days to manually sift through and compile data from paper reports related to print volumes and other pertinent statistics, a consultant who had originally been assigned the task of developing three- and five-year total cost of ownership (TCO) projections estimated he would need at least six months to complete the data collection in order to assess potential savings areas. Managed Print Service technology, however, was able to automate the data collection and report results in significantly less time, quickly identifying three-year TCO reductions in excess of $500,000.

Eight Little Known Facts about Healthcare Printing

  1. Output Growth: Experts say annual print volumes are increasing by as much as 9 percent in black and white and 19 percent in color print processes, 11 percent overall.
  2. Per-User Costs: Analysts estimate that the average healthcare employee generates between $850 and $1,000 per year in document output costs.
  3. Help Desk Woes: As many as half of all calls to a hospital’s help desk are related to print issues.
  4. Waste Reduction: Up to 25 percent of consumables and parts are wasted, something which can often be significantly reduced with predictive ordering.
  5. Ink the Deal: Early cartridge replacement prompts are responsible for as much as 15% of ink supplies waste.
  6. Be Aware: Desktop-connected printers can be the most expensive component of the printer fleet on a per-page basis, tend to be underutilized, have more expensive supplies, and are complex to track and manage.
  7. Significant Savings: A first-year average return on investment for a Managed Print Service solution is as high as 35 percent of the hospital’s print-related expenses.
  8. HIPAA-Safe: Managed Print Service providers never see the actual documents, just the volume data, which means there is no possibility for a HIPAA violation to occur.

About Logicalis

Logicalis is an international IT solutions and managed services provider with a breadth of knowledge and expertise in communications and collaboration, data center and cloud services, and managed services.

Logicalis employs over 4,000 people worldwide, including highly trained service specialists who design, specify, deploy and manage complex IT infrastructures to meet the needs of almost 6,000 corporate and public sector customers.  To achieve this, Logicalis maintains strong partnerships with technology leaders such as Cisco, HP, IBM, EMC, NetApp, Microsoft, VMware and ServiceNow on an international basis and has specialized solutions for enterprise and medium-sized companies in vertical markets covering financial services, telecommunications, media and technology, education, healthcare, retail, government, manufacturing and professional services helping customers benefit from cutting-edge technologies in a cost-effective way.

The Logicalis Group has annualized revenues of over $1.5 billion from operations in Europe, North America, Latin America and Asia Pacific and is one of the leading IT and communications solution integrators specializing in the areas of advanced technologies and services.

The Logicalis Group is a division of Datatec Limited, listed on the Johannesburg and London AIM Stock Exchanges, with revenues of approximately $6 billion.

For more information, visit www.us.logicalis.com.

I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Medicare Limiting Coverage of Drug Sensitivity Testing as of June 22, 2015

New Ruling a Setback for Promise of Personalized Medicine

Seattle, WA (June 3, 2015) — On June 22, 2015, Medicare will begin denying coverage for the majority of genetic drug sensitivity (pharmacogenetic) testing that it has reimbursed since 2009.

Payment denial is expected to impact as many as 19 million of the 49 million Medicare beneficiaries in the U.S. who are at special risk of costly and life-threatening adverse drug events.1 Sadly, if it became a standard of care, this testing could save Medicare millions.

Precision Medicine, the use of an individual’s genetic information to tailor treatment, is by all accounts the future of healthcare. Despite the large body of clinical research supporting the utility of this testing – 17,000 pieces of clinical literature and counting – Medicare’s judgement that there is insufficient evidence to demonstrate that genetic testing improves clinical outcomes could set back adoption of this life-saving test by years.

What is Pharmacogenetic Testing?

Pharmacogenetic (PGx) testing reveals genetic variations that determine how the body metabolizes many of the most commonly prescribed medications. The testing reduces “trial-and-error” prescribing by enabling doctors to prescribe the most effective drug and dose the first time, potentially reducing side effects while saving both the patient and the healthcare system as a whole time and money.

Why is Pharmacogenetic Testing Important?

Research has shown that three out of four people have a genetic variation affecting their response to drugs. Genetically determined variation in drug response is so common that the FDA has included information about drug-gene interactions on more than 130 medication product inserts.

The potential cost-savings of widespread pharmacogenetic testing is huge.  According to the CDC, adverse drug events cost the U.S. health system approximately $3.5 billion annually.2 More than a third of potential clinically significant drug interactions, a potential cause of adverse drug events, have been shown to involve genetics.3  Recent analysis of the recently released CMS Medicare Part D prescription drug data from 2013 suggests:

  • $1.5 billion and 38,000 lives — that’s what genetic testing could potentially save for acute coronary syndrome (ACS) patients receiving percutaneous coronary intervention (PCI), who are on the heart medications clopidogrel (Plavix), prasugrel, and ticragelor. In total, 2.9 million Medicare recipients were on at least one of these medications. Medicare spent $894 million on these drugs combined, with Plavix/clopidogrel costs representing 80 percent of that figure.4
  • Between 560,000 and 1.1 million Medicare recipients could be experiencing ineffective pain relief due to genetic variability while taking hydrocodone-acetaminophen, the prescription painkiller taken by the highest number of Medicare patients. In 2013, Medicare spent roughly $567 million on this drug for 8 million individual beneficiaries (about $70 per person). This is even more alarming considering untreated pain is a leading cause for falls, leading to hospitalization in the elderly.

Impact on the Elderly

Statistics show that adverse drug reactions, a specific subset of adverse drug events, cause 1 in 8 hospitalizations, with the elderly being twice as likely to be hospitalized by an adverse drug reaction compared to the non-elderly.5,6 Though it’s unclear how many of these are caused by drug-gene interactions, many Medicare patients are at particularly high risk, since 44 percent of men and 57 percent of women over 65 take five or more medications per week.7 Additionally, the metabolism of six of the top 10 drugs by Medicare claim count is potentially affected by genetics.

“Pharmacogenetic testing has been a covered benefit since 2009. Denying payment for these medically necessary tests is counter to the Triple Aim. Use of these tests could help doctors avoid unnecessary treatment failures and dangerous side effects; plus could reduce the more than $2000 per patient per year Medicare spends on adverse drug events,” said Kristine Ashcraft, Chief Operating Officer at Genelex. “This testing is the underpinning of precision medicine that President Obama recently called out as a national priority, and is required for better patient care.”

The potential for improvements in patient care and costs are not lost on physicians, whose use of PGx testing continues to be on the rise. A 2012 survey published in Clinical Pharmacology and Therapeutics reports that 12 percent of physicians have ordered PGx testing in the last six months, and 26 percent anticipate ordering a test in the next six months.8 A survey completed in 2014, published in the journal Pharmacogenomics and Personalized Medicine, found that 20 percent of surveyed physicians had ordered a PGx test in the last year.9

Drug sensitivity tests remain available after June 22 from Genelex and other laboratories. Medicare patients talking multiple medications, experiencing treatment failures or unwanted side effects are encouraged to request this testing before the cut-off date (the public is encouraged to visit this patient information site:  http://genelex.com/seniors).  See links below for further information about Medicare and pharmacogenetic testing.

#   #   #

About Genelex

Genelex is a pioneer in comprehensive medication management, pharmacogenetic testing and analysis. Its patented YouScript® Personalized Prescribing Software is the only commercially-available medication management system to assess the cumulative effect of a patient’s genetics and entire drug regimen.  YouScript is an Allscripts Developer Program Approved Application and is used by healthcare providers, clinical researchers and managed and accountable care organizations. Founded in 1987, Genelex is based in Seattle and was one of the first labs to provide pharmacogenetic testing and interpretation. For more information, please go to: www.genelex.com or www.youscript.com.

Sources 

  1. Based on current figures from the Kaiser Foundation in a recent study about the incidence of high-risk medications in patients 65 and over, and phenotype frequency data.
  1. http://www.cdc.gov/medicationsafety/basics.html
  1. Verbeurgt P, Mamiya T, Oesterheld J. How common are drug and gene interactions? Prevalence in a sample of 1143 patients with CYP2C9, CYP2C19 and CYP2D6 genotyping. Pharmacogenomics. 2014;15(5):655-65. Epub 2014/05/07. doi: 10.2217/pgs.14.6. PubMed PMID: 24798722.
  2. Figures are based on an economic model created to show the possible positive impact of pharmacogenetic testing on ACS/PCI patients, using recently released CMS Medicare Part D prescription drug data that detailed how many Medicare patients were prescribed clopidogrel (also known as Plavix), prasugrel, and ticragelor in 2013.
  1. Jansen PA, Brouwers JR. Clinical pharmacology in old persons. Scientifica. 2012;2012:723678. PubMed PMID: 24278735
  1. Beijer HJ, de Blaey CJ. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharmacy world & science : PWS. 2002;24(2):46-54.
  1. Woodruff B. Preventing polypharmacy in older adults. American Nursing Today. 2010; 5(10). Available from: http://www.americannursetoday.com/preventing-polypharmacy-in-older-adults/
  1. Stanek EJ, Sanders CL, Taber KA, Khalid M, Patel A, Verbrugge RR, et al. Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey. Clin Pharmacol Ther. 2012;91(3):450-8. PubMed PMID: 22278335.
  1. Johansen Taber KA, Dickinson BD. Pharmacogenomic knowledge gaps and educational resource needs among physicians in selected specialties. Pharmgenomics Pers Med. 2014;7:145-62. PubMed PMID: 25045280.
June 3, 2015 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.